09.07.2019 Views

Diagnostic Ultrasound - Abdomen and Pelvis

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Pheochromocytoma<br />

600<br />

Diagnoses: Adrenal Gl<strong>and</strong><br />

Adrenocortical Carcinoma<br />

• Rare; aggressive; large, unilateral, heterogeneous solid with<br />

necrosis; hemorrhage ± calcification<br />

• ↑ T1 <strong>and</strong> ↓ T2 signal (as with "classic"<br />

pheochromocytomas)<br />

• Aggressive, often with IVC extension<br />

Adrenal Neuroblastoma<br />

• Large pediatric adrenal mass; calcification (80-90%)<br />

Adrenal Granulomatous Infection<br />

• TB, histoplasmosis, other fungal diseases; usually bilateral<br />

○ Acute (hypoechoic masses) or chronic (small & calcified)<br />

PATHOLOGY<br />

General Features<br />

• Associated abnormalities<br />

○ Majority are sporadic<br />

○ 25% have autosomal dominant gene mutation<br />

– Multiple endocrine neoplasia, type II (MEN2)<br />

□ MEN2 mutation; 50% have pheochromocytoma<br />

□ Medullary thyroid carcinoma; hyperparathyroidism;<br />

neuromas <strong>and</strong> marfanoid habitus<br />

– von Hippel-Lindau (VHL) disease<br />

□ VHL tumor suppressor gene, 10-20% risk<br />

□ Multiple benign <strong>and</strong> malignant tumors<br />

– Neurofibromatosis, type I<br />

□ Rare cause of pheochromocytomas (1% risk)<br />

□ Cutaneous/plexiform neurofibromas, optic nerve<br />

gliomas, peripheral nerve sheath tumors,<br />

gastrointestinal stromal tumor<br />

– Pheochromocytoma-paraganglioma syndromes<br />

□ Mutations of succinate dehydrogenase gene family<br />

(SDHB <strong>and</strong> SDHD)<br />

□ ↑ incidence of extraadrenal tumors <strong>and</strong> head/neck<br />

paragangliomas<br />

□ 50% risk of malignant pheochromocytomas<br />

• Most are benign; 10% are malignant<br />

○ Diagnosis of malignancy is based solely on presence of<br />

direct local tumor invasion or metastatic disease<br />

○ Extraadrenal paragangliomas are more likely to be<br />

malignant<br />

Gross Pathologic & Surgical Features<br />

• Range of appearances: Small, well-circumscribed, yellowtan<br />

lesion confined to adrenals; large, hemorrhagic, cysticnecrotic<br />

masses<br />

Microscopic Features<br />

• Predominantly chromaffin cells; occasionally spindle cells<br />

are dominant feature<br />

○ Term pheochromocytoma refers to dusky color of cells<br />

stained with chromium salts<br />

• No single histologic feature of pheochromocytoma<br />

consistently predicts malignancy<br />

CLINICAL ISSUES<br />

Presentation<br />

• Most common signs/symptoms<br />

○ Majority are asymptomatic; symptoms may be episodic<br />

or paroxysmal<br />

○ Classic triad (arises from adrenergic excess)<br />

– Paroxysmal headache, palpitations, sweating<br />

– 90% specific but uncommon (only present in 10.0-<br />

36.5% of patients)<br />

• Other signs/symptoms<br />

○ Hypertensive crisis: Palpitations, tremors, arrhythmias,<br />

pain, myocardial infarction<br />

• Lab data<br />

○ Tumors typically secrete norepinephrine > epinephrine<br />

○ ↑ levels of 24-hour urine-fractionated metanephrines<br />

– 90-97% sensitivity; 69-98% specificity<br />

Demographics<br />

• Age<br />

○ Sporadic cases, 3rd <strong>and</strong> 4th decades (mean age: 44 years)<br />

○ Hereditary cases (mean age: 25 years)<br />

○ 10% are found in children<br />

• Gender<br />

○ Slight female predilection (M:F = 1:1.4)<br />

• Epidemiology<br />

○ Incidence (exact unknown): Estimated at 2-8 cases/1<br />

million people/year<br />

– 0.1-0.6% of hypertensive adults<br />

○ Majority of pheochromocytomas are likely asymptomatic<br />

(incidentalomas)<br />

– Autopsy occurrence rates 10-17%<br />

Natural History & Prognosis<br />

• Hypertensive crises <strong>and</strong> cardiovascular complications ↑<br />

morbidity/mortality<br />

• Prognosis<br />

○ Noninvasive <strong>and</strong> nonmetastatic: Typically favorable<br />

– Postoperatively: 50% have persistent hypertension;<br />

16% recur within 10 years of resection<br />

○ Malignant tumors: 54% 5-year survival rate<br />

Treatment<br />

• Symptomatic therapy: α-adrenergic blockade <strong>and</strong> calcium<br />

channel antagonists<br />

• Laparoscopic resection/debulking for both benign <strong>and</strong><br />

malignant tumors<br />

• Adjuvant therapy (malignant tumors): I-131 MIBG therapy ±<br />

chemotherapy (cyclophosphamide, vincristine, dacarbazine)<br />

DIAGNOSTIC CHECKLIST<br />

Consider<br />

• Imaging characteristics can mimic other diagnoses; labs<br />

essential for diagnosis<br />

Image Interpretation Pearls<br />

• Extraadrenal tumors arise anywhere along sympathetic<br />

ganglia (neck to bladder); include in search pattern<br />

SELECTED REFERENCES<br />

1. Lattin GE Jr et al: From the radiologic pathology archives: adrenal tumors<br />

<strong>and</strong> tumor-like conditions in the adult: radiologic-pathologic correlation.<br />

Radiographics. 34(3):805-29, 2014<br />

2. Leung K et al: Pheochromocytoma: the range of appearances on ultrasound,<br />

CT, MRI, <strong>and</strong> functional imaging. AJR Am J Roentgenol. 200(2):370-8, 2013<br />

3. Raja A et al: Multimodality imaging findings of pheochromocytoma with<br />

associated clinical <strong>and</strong> biochemical features in 53 patients with histologically<br />

confirmed tumors. AJR Am J Roentgenol. 201(4):825-33, 2013

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!